London, April 18 ANI | 3 months ago

Cardiff University scientists have made significant breakthrough in the treatment of Leukaemia by developing drugs which target the disease at a molecular level.


A team at the institute of cancer and genetics at the University Hospital of Wales has developed a new drug that targets cancer cells in chronic lymphocytic leukaemia patients, stopping them in their tracks before they have time to multiply and travel through the body, the BBC reported.

Lead researcher Prof Chris Pepper, who has worked on the disease for 20 years, said that the new drug will transform the outlook for patients and predicted that within 10 years this disease will become much less of a clinical problem.

(Posted on 18-04-2014)